ENOV 241220 35.00C (ENOV241220C35000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

ENOV241220C35000

Watchlist

8.20
0.000.00%

15min DelayClose Dec 4 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

4 Metal Fabrication Stocks to Watch Amid Improving Industry Trends
Zacks Nov 22 07:50 ET
Enovis Corporation Management to Participate in Upcoming Investor Conferences
Quiver QuantitativeNov 18 16:21 ET
Enovis to Participate in Upcoming Investor Conferences
GlobeNewswireNov 18 16:10 ET
Roth MKM Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $75
Moomoo NewsNov 7 10:31 ET · Ratings
CCORF Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $75
Moomoo NewsNov 7 09:31 ET · Ratings
Wells Fargo Maintains Enovis Corp(ENOV.US) With Buy Rating, Announces Target Price $62
Moomoo NewsNov 7 05:31 ET · Ratings

Comments

Moomoo AI

Feb 26 07:55

The company's use of debt is seen as risky due to its EBIT loss and the liabilities it has. The balance sheet is not considered strong, but it could improve over time. The stock is considered quite risky.

Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt

Moomoo AI

Feb 25 17:55

Needham analysts predict Enovis's new products, orthopedic market strength, and the Lima acquisition will exceed 2024 consensus. They also foresee Paragon 28 returning to roughly 20% revenue growth in 2024 due to new bunion-focused products, supply chain enhancements, and sales force growth.

Needham Sees Orthopedics Market Slowing; Favors Enovis, Paragon 28

Moomoo AI

Dec 5, 2023 05:10

Enovis CEO Matt Trerotola praised Shirley, Vogt, and Ross for their roles in the company's growth. He highlighted Shirley's influence on Enovis's transformation to a medtech firm, Vogt's contribution to the U.S. surgical business growth, and Ross's work in ensuring sustained growth in the P&R segment.

Press Release: Enovis Announces Business Segment Leadership Transition Plan

Moomoo AI

Nov 30, 2023 07:01

Enovis' falling revenue and absent profits might have led to a drop in share price. Viewing the total shareholder return and recent share price rise, the company may suggest investment potential if it shows sustainable long term growth.

Enovis (NYSE:ENOV) Shareholders Have Endured a 21% Loss From Investing in the Stock Three Years Ago

Moomoo AI

Nov 3, 2023 09:26

Enovis's rise in liabilities and recent EBIT loss spark concerns about its debt use and future profitability. With a negative free cash flow of US$106m over the past year, the company's financial risk is evident. Balance sheet situation calls for caution due to dubious circumstances.

Would Enovis (NYSE:ENOV) Be Better Off With Less Debt?